Further Functional in Vitro Comparison of Pre- and Postsynaptic Dopamine Receptors in the Rabbit Caudate Nucleus
Overview
Affiliations
Slices of the rabbit caudate nucleus were preincubated with 3H-dopamine or 3H-choline and then superfused and stimulated electrically. DiPr-5,6-ADTN reduced the stimulation-evoked overflow of tritium over the same concentration range, independently of whether slices had been preincubated with 3H-dopamine or 3H-choline, and the same was true for apomorphine, NPA and pergolide. Three other putative dopamine receptor agonists, namely 3-PPP, DPI and SKF 38393, failed to decrease the evoked overflow of tritium. Each of six antagonists--(-)-sulpiride, (+)-sulpiride, CGP 11109 A, cis-flupentixol, domperidone and corynanthine--increased the evoked overflow over the same concentration range in experiments with 3H-dopamine and in those with 3H-choline. For each of these antagonists except cis-flupentixol, and also for chlorpromazine, haloperidol and rauwolscine, the pA2 values against apomorphine obtained in 3H-dopamine and in 3H-choline experiments were closely similar. The antagonist effect of cis-flupentixol against apomorphine was not purely competitive. (-)-Sulpiride was a more potent antagonist than (+)-sulpiride, and cis-flupentixol was more potent than trans-flupentixol. This study supplements a previous one in which (+/-)-sulpiride, metoclopramide and molindone were used as antagonists. It is a functional in vitro approach to receptor characterization, as opposed to radioligand binding studies or in vivo investigations. The results show that a large number of dopamine receptor agonists and antagonists are unable to distinguish between the presynaptic, release-inhibiting dopamine autoreceptors and those postsynaptic dopamine receptors which, when activated, depress the release of acetylcholine.(ABSTRACT TRUNCATED AT 250 WORDS)
Markstein R, Gull P, Rudeberg C, Urwyler S, Jaton A, Kalkman H J Neural Transm (Vienna). 1996; 103(1-2):17-30.
PMID: 9026371 DOI: 10.1007/BF01292613.
SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity.
Markstein R, Gull P, Rudeberg C, Urwyler S, Jaton A, McAllister K J Neural Transm (Vienna). 1996; 103(3):261-76.
PMID: 8739838 DOI: 10.1007/BF01271238.
Release-regulating dopamine autoreceptors in human cerebral cortex.
Fedele E, Andrioli G, Ruelle A, Raiteri M Br J Pharmacol. 1993; 110(1):20-2.
PMID: 8106101 PMC: 2176017. DOI: 10.1111/j.1476-5381.1993.tb13765.x.
Trendelenburg A, Starke K, Limberger N Naunyn Schmiedebergs Arch Pharmacol. 1994; 350(5):473-81.
PMID: 7870186 DOI: 10.1007/BF00173016.
3H-Dopamine binding sites differ in rat striatum and pituitary.
Sokoloff P, Martres M, Delandre M, Redouane K, Schwartz J Naunyn Schmiedebergs Arch Pharmacol. 1984; 327(3):221-7.
PMID: 6493362 DOI: 10.1007/BF00502453.